{"id":1419,"date":"2026-06-14T21:20:33","date_gmt":"2026-06-14T21:20:33","guid":{"rendered":"https:\/\/curetaok1.org\/?page_id=1419"},"modified":"2026-08-14T16:22:55","modified_gmt":"2026-08-14T16:22:55","slug":"registry-intake","status":"publish","type":"page","link":"https:\/\/curetaok1.org\/?page_id=1419","title":{"rendered":"Registry intake"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In brief<\/h2>

We are building a TAOK1 patient registry – a secure, consent-based way for families from around the world to contribute information that helps researchers understand the natural history of TAOK1-associated disorder. On this page we explain what such a registry is, what the natural history of a disease means, and why this is one of the most important projects we can carry out as a community.<\/p>

What is a patient registry?<\/h3>

A patient registry is a structured, continuously maintained database of information about people with a given condition – their symptoms, development, test results, and the course of their care. Data enter the registry only voluntarily and with the family’s informed consent, are properly secured, and are made available – under clearly defined rules – to research teams working on the condition.<\/p>

For a condition as rare as TAOK1-NDD, the importance of a registry is hard to overstate. Fewer than one hundred people with this diagnosis have been documented in the scientific literature worldwide, and an individual doctor or center usually sees one, perhaps a few, patients. No single hospital is therefore able to gather knowledge about the full spectrum of the condition on its own. A registry reverses this situation: it brings together the experiences of families scattered around the world into one coherent picture that researchers can draw on regardless of where they work.<\/p>

What is the natural history of a disease?<\/h3>

The natural history of a disease is its course over time without causal treatment – from the first symptoms, through successive stages of development, to functioning in adulthood. A natural history study involves systematically observing patients over many years and documenting how the disease progresses in different people and which factors (e.g., the type of genetic variant) are associated with a milder or more severe course.<\/p>

For TAOK1-NDD, such data essentially do not yet exist. The condition was described only in 2019, and the vast majority of documented patients are children – so science does not yet know what the disorder looks like across a whole lifetime. This is, in fact, a typical situation: as the U.S. Food and Drug Administration (FDA) emphasizes, for most rare diseases natural history information is unavailable or incomplete – and that is precisely why it is so badly needed.<\/p>

Why is natural history the key to future therapies?<\/h3>

It might seem that observational data collection is the less exciting side of science. In reality, the opposite is true: a well-documented natural history is the foundation without which no causal treatment can be developed and tested. According to the FDA’s guidance on natural history studies in rare diseases, these data serve, among other things, to:<\/p>